We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGB
1851
Blackstone Strategic Credit 2027 Term Fund
BGB
$506M
$1.41M ﹤0.01%
104,676
-13,194
-11% -$195K
GDO
1852
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77.8M
$1.41M ﹤0.01%
93,865
-16,577
-15% -$254K
SCHA icon
1853
Schwab U.S Small- Cap ETF
SCHA
$23.3B
$1.41M ﹤0.01%
92,712
+51,924
+127% +$877K
COLM icon
1854
Columbia Sportswear
COLM
$2.87B
$1.4M ﹤0.01%
16,701
-1,377
-8% -$122K
CHY
1855
Calamos Convertible and High Income Fund
CHY
$1.08B
$1.4M ﹤0.01%
149,180
-15,675
-10% -$167K
VVC
1856
DELISTED
Vectren Corporation
VVC
$1.4M ﹤0.01%
19,480
-2,174
-10% -$156K
KT icon
1857
KT
KT
$8.88B
$1.4M ﹤0.01%
98,463
-5,540
-5% -$80.2K
PPBI
1858
DELISTED
Pacific Premier Bancorp
PPBI
$1.4M ﹤0.01%
54,869
+12,935
+31% +$391K
PCH
1859
DELISTED
PotlatchDeltic
PCH
$1.4M ﹤0.01%
44,122
+24,057
+120% +$859K
RDFN
1860
DELISTED
Redfin
RDFN
$1.4M ﹤0.01%
96,844
-53,606
-36% -$851K
KIE icon
1861
State Street SPDR S&P Insurance ETF
KIE
$676M
$1.39M ﹤0.01%
49,134
-5,029
-9% -$151K
VBF icon
1862
Invesco Bond Fund
VBF
$169M
$1.39M ﹤0.01%
82,949
-10,106
-11% -$174K
GDEN
1863
DELISTED
Golden Entertainment
GDEN
$1.39M ﹤0.01%
86,746
+2,000
+2% +$36.4K
HRB icon
1864
H&R Block
HRB
$6.93B
$1.39M ﹤0.01%
54,728
+35,895
+191% +$958K
CRSP icon
1865
CRISPR Therapeutics
CRSP
$5.25B
$1.39M ﹤0.01%
48,557
+5,227
+12% +$182K
STBZ
1866
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.39M ﹤0.01%
64,234
-246
-0.4% -$6.13K
EAF icon
1867
GrafTech
EAF
$204M
$1.39M ﹤0.01%
12,113
+2,362
+24% +$361K
AVAV icon
1868
AeroVironment
AVAV
$9.77B
$1.38M ﹤0.01%
20,371
+2,291
+13% +$201K
SGEN
1869
DELISTED
Seagen Inc. Common Stock
SGEN
$1.38M ﹤0.01%
24,429
+2,326
+11% +$146K
MD icon
1870
Pediatrix Medical
MD
$2.14B
$1.38M ﹤0.01%
41,898
-4,098
-9% -$165K
PAAS icon
1871
Pan American Silver
PAAS
$22.2B
$1.38M ﹤0.01%
94,719
-582
-0.6% -$8.32K
NBH
1872
Neuberger Municipal Fund Inc
NBH
$303M
$1.38M ﹤0.01%
109,081
+1,996
+2% +$25.7K
DBRG icon
1873
DigitalBridge
DBRG
$2.95B
$1.38M ﹤0.01%
73,546
-312,146
-81% -$7.14M
KCE icon
1874
State Street SPDR S&P Capital Markets ETF
KCE
$472M
$1.38M ﹤0.01%
28,819
-174,423
-86% -$9.03M
KNOP icon
1875
KNOT Offshore Partners
KNOP
$361M
$1.38M ﹤0.01%
76,711
-6,884
-8% -$139K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.